186 related articles for article (PubMed ID: 36314067)
61. Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma.
Niu C; Qiu W; Li X; Li H; Zhou J; Zhu H
J Cancer; 2022; 13(8):2584-2593. PubMed ID: 35711845
[TBL] [Abstract][Full Text] [Related]
62. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
63. Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy.
Pácal L; Tomandl J; Svojanovsky J; Krusová D; Stepánková S; Rehorová J; Olsovsky J; Belobrádková J; Tanhäuserová V; Tomandlová M; Muzík J; Kanková K
Nephrol Dial Transplant; 2011 Apr; 26(4):1229-36. PubMed ID: 20826743
[TBL] [Abstract][Full Text] [Related]
64. Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma.
Lao Y; Cui X; Xu Z; Yan H; Zhang Z; Zhang Z; Geng L; Li B; Lu Y; Guan Q; Pu X; Zhao S; Zhu J; Qin X; Sun B
J Hepatol; 2024 May; ():. PubMed ID: 38825017
[TBL] [Abstract][Full Text] [Related]
65. Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.
Kovářová J; Pountain AW; Wildridge D; Weidt S; Bringaud F; Burchmore RJS; Achcar F; Barrett MP
PLoS Pathog; 2018 Mar; 14(3):e1006953. PubMed ID: 29554142
[TBL] [Abstract][Full Text] [Related]
66. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma.
Hong M; Almutairi MM; Li S; Li J
Phytomedicine; 2020 Mar; 68():153174. PubMed ID: 31991293
[TBL] [Abstract][Full Text] [Related]
67. Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29.
Vizán P; Alcarraz-Vizán G; Díaz-Moralli S; Solovjeva ON; Frederiks WM; Cascante M
Int J Cancer; 2009 Jun; 124(12):2789-96. PubMed ID: 19253370
[TBL] [Abstract][Full Text] [Related]
68. A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.
Yang H; Chen D; Wu Y; Zhou H; Diao W; Liu G; Li Q
Cancer Metab; 2023 Dec; 11(1):27. PubMed ID: 38111012
[TBL] [Abstract][Full Text] [Related]
69. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC.
Kim MJ; Choi YK; Park SY; Jang SY; Lee JY; Ham HJ; Kim BG; Jeon HJ; Kim JH; Kim JG; Lee IK; Park KG
Mol Cancer Res; 2017 Sep; 15(9):1230-1242. PubMed ID: 28584024
[TBL] [Abstract][Full Text] [Related]
70. Improvement of neuronal differentiation by carbon monoxide: Role of pentose phosphate pathway.
Almeida AS; Soares NL; Sequeira CO; Pereira SA; Sonnewald U; Vieira HLA
Redox Biol; 2018 Jul; 17():338-347. PubMed ID: 29793167
[TBL] [Abstract][Full Text] [Related]
71. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
72. Transketolase-like protein 1 confers resistance to serum withdrawal in vitro.
Hartmannsberger D; Mack B; Eggert C; Denzel S; Stepp H; Betz CS; Gires O
Cancer Lett; 2011 Jan; 300(1):20-9. PubMed ID: 20884117
[TBL] [Abstract][Full Text] [Related]
73. Oroxylin a promoted apoptotic extracellular vesicles transfer of glycolytic kinases to remodel immune microenvironment in hepatocellular carcinoma model.
Wang P; Cao J; Feng Z; Tang Y; Han X; Mao T; Li S; Guo Q; Ke X; Zhang X
Eur J Pharmacol; 2023 Oct; 957():176037. PubMed ID: 37660969
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
[TBL] [Abstract][Full Text] [Related]
75. KDM6A promotes hepatocellular carcinoma progression and dictates lenvatinib efficacy by upregulating FGFR4 expression.
Guo W; Li S; Qian Y; Li L; Wang F; Tong Y; Li Q; Zhu Z; Gao WQ; Liu Y
Clin Transl Med; 2023 Oct; 13(10):e1452. PubMed ID: 37846441
[TBL] [Abstract][Full Text] [Related]
76. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
77. Transketolase drives the development of aortic dissection by impairing mitochondrial bioenergetics.
Wang C; Zhang L; Zhang Q; Zheng H; Yang X; Cai W; Zou Q; Lin J; Zhang L; Zhong L; Li X; Liao Y; Liu Q; Chen L; Li Y
Acta Physiol (Oxf); 2024 Apr; 240(4):e14113. PubMed ID: 38380737
[TBL] [Abstract][Full Text] [Related]
78. The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases.
Deshpande GP; Patterton HG; Faadiel Essop M
BMC Struct Biol; 2019 Jan; 19(1):2. PubMed ID: 30646877
[TBL] [Abstract][Full Text] [Related]
79. Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport.
Aleshin VA; Kaehne T; Maslova MV; Graf AV; Bunik VI
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255994
[TBL] [Abstract][Full Text] [Related]
80. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
